Vector Insert-Targeted Integrative Antisense Expression System for Plasmid Stabilization
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Some DNA vaccine and gene therapy vector-encoded transgenes are toxic to the E. coli plasmid production host resulting in poor production yields. For plasmid products undergoing clinical evaluation, sequence modification to eliminate toxicity is undesirable because an altered vector is a new chemical entity. We hypothesized that: (1) insert-encoded toxicity is mediated by unintended expression of a toxic insert-encoded protein from spurious bacterial promoters; and (2) that toxicity could be eliminated with antisense RNA-mediated translation inhibition. We developed the pINT PR PL vector, a chromosomally integrable RNA expression vector, and utilized it to express insert-complementary (anti-insert) RNA from a single defined site in the bacterial chromosome. Anti-insert RNA eliminated leaky fluorescent protein expression from a target plasmid. A toxic retroviral gag pol helper plasmid produced in a gag pol anti-insert strain had fourfold improved plasmid fermentation yields. Plasmid fermentation yields were also fourfold improved when a DNA vaccine plasmid containing a toxic Influenza serotype H1 hemagglutinin transgene was grown in an H1 sense strand anti-insert production strain, suggesting that in this case toxicity was mediated by an antisense alternative reading frame-encoded peptide. This anti-insert chromosomal RNA expression technology is a general approach to improve production yields with plasmid-based vectors that encode toxic transgenes, or toxic alternative frame peptides.
- Kutzler, M. A., & Weiner, D. B. (2008). DNA vaccines: Ready for prime time? Nature Reviews Genetics, 9, 776–788. CrossRef
- Williams, J. A., Carnes, A. E., & Hodgson, C. P. (2009). Plasmid DNA vector design; impact on efficacy, safety and upstream production. Biotechnology Advances, 27, 353–370. CrossRef
- Mairhofer, J., & Grabherr, R. (2008). Rational vector design for efficient non-viral gene delivery: Challenges facing the use of plasmid DNA. Molecular Biotechnology, 39, 97–104. CrossRef
- Engels, P., & Meyer, P. (1993). Inactivation of the transcriptional-dependent inhibition of plasmid replication: a selection method for cloning large DNA fragments. Biotechniques, 14, 324–325.
- Brosius, J. (1984). Toxicity of an overproduced foreign gene product in Escherichia coli and its use in plasmid vectors for the selection of transcription terminators. Gene, 27, 161–172. CrossRef
- Chen, W., Kallio, P. T., & Bailey, J. E. (1993). Construction and characterization of a novel cross-regulation system for regulating cloned gene expression in Escherichia coli. Gene, 130, 15–22. CrossRef
- Chen, J. D., & Morrision, D. A. (1987). Cloning of Streptococcus pneumoniae DNA fragments in Escherichia coli requires vectors protected by strong transcriptional terminators. Gene, 55, 179–187. CrossRef
- Cooke, J. R., McKie, E. A., Ward, J. M., & Keshavarz-Moore, E. (2004). Impact of intrinsic DNA structure on processing of plasmids for gene therapy and DNA vaccines. Journal of Biotechnology, 114, 239–254. CrossRef
- Weiner, D. B., Zhang, D., & Cohen, A. (2005). Expression system for cloning toxic genes. United States Patent 6881558.
- Saida, F., Uzan, M., Odaert, B., & Bontems, F. (2006). Expression of highly toxic genes in E. coli: Special strategies and genetic tools. Current Protein and Peptide Science, 7, 47–56. CrossRef
- Boyd, A. C., Popp, F., Michaelis, U., Davidson, H., Davidson-Smith, H., Doherty, A., et al. (1999). Insertion of natural intron 6a–6b into a human cDNA-derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination. Journal of Gene Medicine, 1, 312–321. CrossRef
- Futterer, J., Gordon, K., Pfeiffer, P., & Hohn, T. (1988). The instability of a recombinant plasmid, caused by a prokaryotic-like promoter within the eukaryotic insert, can be alleviated by expression of antisense RNA. Gene, 67, 141–145. CrossRef
- Haldimann, A., & Wanner, B. L. (2001). Conditional-replication, integration, excision, and retrieval plasmid-host systems for gene structure-function studies of bacteria. Journal of Bacteriology, 183, 6384–6393. CrossRef
- Williams, J. A., Luke, J., Langtry, S., Anderson, S., Hodgson, C. P., & Carnes, A. E. (2009). Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes. Biotechnology and Bioengineering, 103, 1129–1143. CrossRef
- Williams, J. A. (2008). Vectors and methods for genetic immunization. WO 2008/153733.
- Carnes, A. E., Hodgson, C. P., Luke, J., Vincent, J., & Williams, J. A. (2009). Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification. Biotechnology and Bioengineering, 104, 505–515. CrossRef
- Kemmer, C., & Neubauer, P. (2006). Antisense RNA based down-regulation of RNase E in E. coli. Microbial Cell Factories, 5, 38. CrossRef
- Luke, J., Carnes, A. E., Hodgson, C. P., & Williams, J. A. (2009). Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system. Vaccine, 27, 6454–6459. CrossRef
- Datsenko, K. A., & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proceedings of the National Academy of Sciences USA, 97, 6640–6645. CrossRef
- Makrides, S. C. (1996). Strategies for achieving high-level expression of genes in Escherichia coli. Microbiological Reviews, 60, 512–538.
- Vector Insert-Targeted Integrative Antisense Expression System for Plasmid Stabilization
Volume 47, Issue 1 , pp 43-49
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- DNA vaccine
- Antisense RNA
- Non-viral vector
- Vector stabilization
- Strain engineering
- Industry Sectors